Collection of samples

BIOLOGICAL5 trials

Sponsors

Elusys Therapeutics, Hôpital NOVO, Institut National de la Santé Et de la Recherche Médicale, France, Centre Hospitalier Universitaire Dijon, Emergent BioSolutions

Conditions

APECEDAntenatal Congenital MalformationsAnthraxAutoimmune AnemiaAutoimmune CytopeniaAutoimmune DiabetesAutoimmune DiseasesAutoimmune Hepatitis

Phase 4

An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis

Elusys TherapeuticsAnthrax, Infection, Bacterial

Start: 2023-12-31End: 2025-12-31Target: 100Updated: 2023-07-14

Unknown Phase

Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients

CompletedNCT04361396

Hôpital NOVOCoronavirus Infection

Start: 2020-06-16End: 2022-01-18Updated: 2024-09-19

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

CompletedNCT04902807

Institut National de la Santé Et de la Recherche Médicale, FranceAPECED, Autoimmune Anemia, Autoimmune Cytopenia +17

Start: 2021-09-07End: 2025-10-21Updated: 2026-09-18

Comparison of the Non-invasive Approach and Fetal Exome Sequencing in Prenatal Diagnosis When Fetal Ultrasound Signs Are Discovered

CompletedNCT05182242

Centre Hospitalier Universitaire DijonAntenatal Congenital Malformations

Start: 2022-03-08End: 2024-03-14Updated: 2025-02-20

Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax

Not yet recruitingNCT07478471

Emergent BioSolutionsInfections, Bacterial

Start: 2027-05-01End: 2030-12-01Target: 10Updated: 2026-03-17

Related Papers

First Prenatal Case of Genotypically and Phenotypically Overlapping Double Molecular Diagnosis of Van den Ende–Gupta and 22q11.2 Deletion Syndromes

Molecular Genetics & Genomic Medicine2025-04-01